Therapy of the aging male;Therapie des "aging male"

Urologe - Ausgabe A

Volumn 44, Issue 10, 2005, Pages 1173-1178

  Diemer, T ^a   Hauck, E W ^a   Rohde, V ^a   Weidner, W ^a  

^a UNIVERSITY HOSPITAL GIESSEN   (Germany)

Author keywords

Aging male; Hormone replacement therapy; Late onset hypogonadism; PADAM; Testosterone

Indexed keywords

ANDROTOP; TESTOSTERONE; TESTOSTERONE UNDECANOATE;

AGING; ANDROPAUSE; ARTICLE; BODY FAT; ENDOCRINE DISEASE; HORMONE SUBSTITUTION; HUMAN; HYPOGONADISM; MOOD; OSTEOPOROSIS; OUTCOMES RESEARCH; PROSTATE; SEXUAL FUNCTION; STRENGTH; SYMPTOMATOLOGY; TESTOSTERONE BLOOD LEVEL; TREATMENT CONTRAINDICATION;

AGED; AGED, 80 AND OVER; AGING; HORMONE REPLACEMENT THERAPY; HUMANS; HYPOGONADISM; IMPOTENCE; MALE; PHYSICIAN'S PRACTICE PATTERNS; PRACTICE GUIDELINES; TESTOSTERONE;

EID: 26844442637     PISSN: 03402592     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00120-005-0906-5     Document Type: Article

References (36)

1. Barnes CJ, Covington BW, Cameron IL, Lee M (1998) Effect of ageing on spontaneous and induced mouse testicular germ cell apoptosis. Aging 10: 497-501
2. Beutel ME, Wiltink J, Hauck EW, Auch D, Behre HM, Brähler E, Weidner W (2005) Correlations between hormones, physical, and affective parameters in aging urologic outpatients. Eur Urol 47: 749-755
3. Bordson BL, Leonardo VS (1991) The appropriate upper age limit for several semen donors: a review of the genetic effects of paternal age. Fertil Steril 56: 397-401
4. Bremner WJ, Vitiello MV, Prinz PN (1983) Loss of circadian rhythmicity in blood testosterone levels with aging in normal men. J Clin Endocrinol Metab 56: 1278-1281
5. Brinkworth MH, Weinbauer GF, Bergmann M, Nieschlag E (1997) Apoptosis as a mechanism of germ cell loss in elderly men. Int J Androl 20: 222-228
6. Chen H, Hardy MP, Huhtaniemi I, Zirkin BR (1994) Age-related decreased Leydig cell testosterone production in the brown Norway rat. J Androl 15: 551-557
7. Chen H, Huhtaniemi I, Zirkin BR (1996) Depletion and repopulation of Leydig cells in the testes of aging brown Norway rats. Endocrinology 137: 3447-3452
8. Chen H, Zirkin BR (1999) Long-term suppression of Leydig cell steroidogenesis prevents Leydig cell aging. Proc Natl Acad Sci USA 96: 14.877-14.881
9. Comhaire FH (2000) Andropause: Hormone replacement therapy in the aging male. Eur Urol 38: 655-662
10. Curran MJ, Bihrle W (1999) Dramatic rise in prostate-specific antigen after androgen replacement in a hypogonadal man with occult adenocarcinoma of the prostate. Urology 53: 423-424
11. Feldman HA, Longcope C, Derby CA et al. (2002) Age trends in the level of serum testosterone and otherhormones in middle-aged men: longitudinal results from the Massachusetts male aging study. J Clin Endocrinol Metab 87: 589-598
12. Ferri M, Norman RW (2000) Prostate cancer in a hypogonadal male receiving androgen supplementation. Can J Urol 7: 1055-1056
13. Fowler JE Jr, Whitmore WF Jr (1981) The response of metastatic adenocarcinoma of the prostate to exogenous testosterone. J Urol 126: 372-375
14. Gerstenbluth RE, Maniam PN, Corty EW, Seftel AD (2002) Prostate-specific antigen changes in hypogonadal men treated with testosterone replacement. J Androl 23: 922-926
15. Gray A, Feldman HA, McKinlay HB, Longcope C (1991) Age, disease and changing sex hormone levels in middle-aged men: Results of the Massachusetts Male Aging Study. J Clin Endocrinol Metab 73: 1016-1025
16. Gruenewald DA, Matsumoto AM (2003) Testosterone supplementation therapy for older men: Potential benefits and risks. J Am Geriatr Soc 51: 101-115
17. Grzywacz FW, Chen H, Allegretti J, Zirkin BR (1998) Does age-associated reduced Leydig celltestosterone production in Brown Norway rats result from under-stimulation by luteinizing hormone? J Androl 19: 625-630
18. Hermann M, Untergasser G, Rumpold H, Berger P (2000) Aging of the male reproductive system. Exp Gerontol 35: 1267-1279
19. Holstein AF, Roosen-Runge EC, Schirren C (1988) Illustrated pathology of human spermatogenesis. Grosse, Berlin
20. Johnson L, Varner DD, Roberts ME, Smith TL, Keilor GE, Scutchfield WL (2000) Efficiency ofspermatogenesis: a comparative approach. Anim Reprod Sci 60-61: 471-480
21. Kaufmann JM (1999) Hypothalamo-pituitary-gonadal function in aging men. Aging Male 2: 157-165
22. Luo L, Chen H, Zirkin BR (1996) Are Leydig cell steroidogenic enzymes differentially regulated withaging? J Androl 17: 509-515
23. Morales A (2002) Androgen replacement therapy and prostate safety. Eur Urol 41: 113-120
24. Nieschlag E, Swerdloff R, Behre HM et al. (2005) Investigation, treatment and monitoring of late-onset hypogonadism in males: ISA, ISSAM, and EAU recommendations. Int J Androl 28: 125-127
25. Oliver RT, Williams G, Paris AM, Blandy JP (1997) Intermittent androgen deprivation after PSA-complete response as a strategy to reduce induction of hormone-resistant prostate cancer. Urology 49: 79-82
26. Ribeiro M, Ruff P, Falkson G (1997) Low serum testosterone and a younger age predict for a poor outcome in metastatic prostate cancer. Am J Clin Oncol 20: 605-608
27. Schill W-B, Köhn FM, Haidl G (1993) The aging male. In: Berg G, Hammar M (eds) The modern management ofthe menopause. Parthenon, New York, pp 545-565
28. Svetec DA, Canby ED, Thompson IM, Sabanegh ES Jr (1997) The effect of parenteral testosterone replacement on prostate specific antigen in hypogonadal men with erectile dysfunction. J Urol 158: 1775-1777
29. Turner HE, Wass JAH (1997) Gonadal function in men with chronic illness. Clin Endocrinol 47: 379-403
30. Veldhuis JD (2000) Recent neuroendocrine facts of male reproductive aging. Exp Gerontol 35: 1281-1308
31. Vermeulen A (1991) Androgens in the aging male - Clinical review 24. J Clin Endocrinol Metab 73: 220-224
32. Vermeulen A, Kaufman JM (1995) Aging of the hypothalamic-pituitary- testicular axis in men. Horm Res 13: 25-28
33. Vermeulen A, Kaufmann JM (1992) Role of the hypothalamo-pituitary function in thehypoandrogenism of healthy aging. J Clin Endocrinol Metab 74: 704-706
34. Weidner W, Altwein J, Hauck E, Beutel M, Brähler E (2001) Sexuality of the Elderly. Urol Int 66: 181-184
35. Wilson DW, Harper ME, Jensen HM et al. (1985) Prognostic index for the clinical management of patients with advanced prostatic cancer: a British Prostate Study Group investigation. Prostate 17: 131-141
36. Zirkin BR, Chen H (2000) Regulation of Leydig cell steroidogenic function during aging. Biol Reprod 63: 977-981